eMedicine Specialties > Pediatrics: Surgery > Urology
Myelodysplasia and Neurogenic Bladder Dysfunction: Differential Diagnoses & Workup
Updated: Mar 27, 2008
- Overview
- Differential Diagnoses & Workup
- Treatment & Medication
- Follow-up
Differential Diagnoses
Other Problems to Be Considered
Spina bifida occulta
Sacral agenesis
Nonneurogenic/neurogenic bladder
Vesicoureteral reflux
Workup
Laboratory Studies
- Obtain urinalysis, urine culture, and serum electrolytes with BUN and creatinine levels before the infant leaves the hospital. BUN and creatinine levels should be tested at least 24 hours after birth to reflect the infant's levels rather than the mother's.
Imaging Studies
- Abdominal ultrasonography: Perform abdominal ultrasonography as soon as possible after birth to detect hydronephrosis or other upper genitourinary (GU) tract pathology. Once the child has recovered from the closure of the spinal defect and is stable for transportation, renal ultrasonography is performed to evaluate upper GU tract anatomy.
- Voiding cystourethrography
- Following ultrasonography, voiding cystourethrography (VCUG) is performed to evaluate the lower GU tract. These studies provide a baseline for the appearance of the upper and lower GU tracts, can facilitate the diagnosis of hydronephrosis or vesicoureteral reflux, and can help identify children at risk for upper GU tract deterioration.
- VCUG is the radiographic test of choice to evaluate for vesicoureteral reflux. The procedure is as follows:
- A supine film of the abdomen is obtained first, including the bladder and kidneys. A small catheter is placed in the child's bladder, and the bladder is filled with contrast.
- A cystogram is obtained with the patient in the supine and oblique positions. The size, shape, and capacity of the bladder are evaluated, as is the presence of trabeculae or diverticula.
- The next film is obtained as the child voids or leaks. When vesicoureteral reflux is present, the bladder, urethra, and ureters are demonstrated. In higher-grade reflux, the renal collecting system also may be seen.
- A final film is obtained after the bladder has been emptied. The presence of reflux is an indication to start prophylactic antibiotics.
- Lateral spine radiography: In suspected sacral agenesis, a lateral spine film is the appropriate imaging study.
- MRI: Ultrasonography of the spinal canal can be useful in infants younger than 5 months; however, once the vertebrae begin to ossify, ultrasonography becomes much less sensitive. The criterion standard for evaluation of spinal cord anatomy is MRI. This is the test of choice when a change in neurologic symptoms causes cord tethering to be suspected.
Other Tests
- Measure of residual urine: As soon as possible, measure the residual urine to determine if IC is necessary. The normal capacity of the newborn bladder is 10-15 mL, and consistent catheterized residual volumes of 10 mL or more should raise concerns regarding detrusor areflexia.
- Urodynamic study
- This test provides the most information regarding the impact of myelodysplasia on bladder function and is used to assess bladder function and guide treatment. Because the bony level often does not always correspond with the neurologic defect that is present, and because the effect of the lesion on bladder function cannot be entirely determined by radiographic studies or physical examination, the information gained from a urodynamic study is invaluable.
- The urodynamic study provides a measurement of several variables related to bladder function. Bladder capacity, compliance, detrusor and abdominal storage, voiding pressures, urine flow rate, postvoiding residual volume, and the relationship between detrusor contraction and the urinary sphincter can be evaluated. In addition, if contrast is instilled in the bladder, the anatomy can be imaged during voiding.
- The core of the urodynamic study is cystometrography (CMG). A small catheter is placed in the bladder, and the bladder is slowly filled with liquid. Pressures within the bladder (intravesical) and the abdominal compartment are measured, and by subtracting the abdominal pressure from the intravesical pressure, the pressure generated by the detrusor muscle can be calculated. Because the child is monitored through a filling and voiding phase, bladder capacity can be quantified, and the urine flow rate, postvoiding residual volume, and the force generated by a bladder contraction can be measured.
- Electromyography: If more information is desired, electromyography (EMG) can be used to demonstrate the relationship between the detrusor muscle and the external urinary sphincter. During normal voiding, the sphincter relaxes as the detrusor muscle contracts to allow unobstructed urinary flow. Spinal cord injury can lead to discoordination so that the sphincter is closed when the detrusor contracts, creating high pressures within the bladder but low flow rates. This is known as detrusor-sphincter dyssynergy (DSD). In infants with DSD, increased EMG activity occurs during voiding. The presence of DSD places infants at a much greater risk of upper GU tract deterioration.
- Fluoroscopy
- Fluoroscopy can be used to perform video-urodynamic imaging with contrast enhancement of the bladder, which allows the bladder to be depicted during voiding. In addition, reflux may be revealed (identical to findings in VCUG) or, if a closed sphincter is revealed during voiding, findings strongly suggest the presence of DSD, often obviating the need for EMG studies.
- Remember that a great number of artifacts can be introduced into urodynamic studies when they are performed in infants and children.
- Comparison of adjunctive data from radiographic studies and voiding or catheterized volume diaries is always advisable during planning of individualized bladder management.
- Common findings are as follows:
- A common diagnosis made using urodynamic studies is detrusor areflexia or a bladder that does not generate contractions. The result is that the bladder will not empty (stasis). These patients can occasionally void with abdominal straining, but, except in rare cases, they need to be managed with IC.
- Another diagnosis is DSD, in which increased sphincter activity occurs during detrusor contractions. This finding is important because DSD has been associated with an increased risk of upper GU tract deterioration in as many as 70% of patients. DSD is typically managed with IC and anticholinergic medications.
- In older patients, sphincterotomy (surgical ablation of the urinary sphincter) can be considered, but this procedure dramatically reduces outlet resistance and usually renders patients incontinent and reliant on an external collection device.
- Detrusor hyperreflexia is defined as the presence of involuntary detrusor contractions, usually at low volumes. This can produce symptoms of urgency and urge incontinence. Treatment is composed of anticholinergic medications to reduce contractions and timed voiding or use of IC.
- Urodynamic studies can also reveal outflow obstruction. In patients with obstruction, high voiding and/or storage pressures are seen, which have been correlated with increased risk of upper GU tract deterioration. This is managed with IC, surgical resection of the obstructing tissue, or urinary diversion (in extreme cases).
- Genetic testing: If multiple anomalies are present, if the sex of the child is in question, or if a specific genetic syndrome is suspected, a karyotype may be of value but is not routinely required.
More on Myelodysplasia and Neurogenic Bladder Dysfunction |
| Overview: Myelodysplasia and Neurogenic Bladder Dysfunction |
Differential Diagnoses & Workup: Myelodysplasia and Neurogenic Bladder Dysfunction |
| Treatment & Medication: Myelodysplasia and Neurogenic Bladder Dysfunction |
| Follow-up: Myelodysplasia and Neurogenic Bladder Dysfunction |
| References |
| « Previous Page | Next Page » |
References
Selzman AA, Elder JS, Mapstone TB. Urologic consequences of myelodysplasia and other congenital abnormalities of the spinal cord. Urol Clin North Am. Aug 1993;20(3):485-504. [Medline].
Shaw GM, Velie EM, Wasserman CR. Risk for neural tube defect-affected pregnancies among women of Mexican descent and white women in California. Am J Public Health. Sep 1997;87(9):1467-71. [Medline].
Kochakarn W, Ratana-Olarn K, Lertsithichai P, Roongreungsilp U. Follow-up of long-term treatment with clean intermittent catheterization for neurogenic bladder in children. Asian J Surg. Apr 2004;27(2):134-6. [Medline].
Bruner JP, Tulipan N, Paschall RL, et al. Fetal surgery for myelomeningocele and the incidence of shunt-dependent hydrocephalus. JAMA. Nov 17 1999;282(19):1819-25. [Medline].
Bruner JP, Richards WO, Tulipan NB, Arney TL. Endoscopic coverage of fetal myelomeningocele in utero. Am J Obstet Gynecol. Jan 1999;180(1 Pt 1):153-8. [Medline].
Meuli M, Meuli-Simmen C, Hutchins GM, et al. In utero surgery rescues neurological function at birth in sheep with spina bifida. Nat Med. Apr 1995;1(4):342-7. [Medline].
Tulipan N, Bruner JP. Myelomeningocele repair in utero: a report of three cases. Pediatr Neurosurg. Apr 1998;28(4):177-80. [Medline].
Akbar M, Abel R, Seyler TM, et al. Repeated botulinum-A toxin injections in the treatment of myelodysplastic children and patients with spinal cord injuries with neurogenic bladder dysfunction. BJU Int. Sep 2007;100(3):639-45. [Medline].
Riccabona M, Koen M, Schindler M, et al. Botulinum-A toxin injection into the detrusor: a safe alternative in the treatment of children with myelomeningocele with detrusor hyperreflexia. J Urol. Feb 2004;171(2 Pt 1):845-8; discussion 848. [Medline].
Bauer SB. Voiding dysfunction in children: Neurogenic and non-neurogenic. In: Walsh PC, Wein AJ, Retik AB, Vaughan ED, eds. Campbell's Urology. Vol 3. 8th ed. WB Saunders Co; 2002:2231-2261.
Bauer SB. The management of the myelodysplastic child: a paradigm shift. BJU Int. Oct 2003;92 Suppl 1:23-8. [Medline].
Bellinger MF. Myelomeningocele and neuropathic bladder. In: Gillenwater JY, Howard SS, Grayhack JT, eds. Adult and Pediatric Urology. 3rd ed. Mosby-Year Book; 1996:2489-528.
Carr MC. Prenatal management of urogenital disorders. Urol Clin North Am. Aug 2004;31(3):389-97, vii. [Medline].
Elliott SP, Villar R, Duncan B. Bacteriuria management and urological evaluation of patients with spina bifida and neurogenic bladder: a multicenter survey. J Urol. Jan 2005;173(1):217-20. [Medline].
Ellsworth P, Gormley EA, Cendron M. Urodynamic testing in the pediatric patient. In: American Urological Associate Update Series. Lesson 12. Vol 18. AUA; 1999:90-5.
Hayashi Y, Yamataka A, Kaneyama K, et al. Review of 86 patients with myelodysplasia and neurogenic bladder who underwent sigmoidocolocystoplasty and were followed more than 10 years. J Urol. Oct 2006;176(4 Pt 2):1806-9. [Medline].
Husmann DA. Occult spinal dysraphism (the tethered cord) and the urologist. In: American Urological Association Update Series. Lesson 10. Vol 14. AUA; 1995:78-83.
Poppas D, Bauer S. Urologic evaluation of the myelodysplastic child. In: American Urological Association Update Series. Lesson 36. Vol 16. AUA; 1997:282-7.
Sakakibara R, Hattori T, Uchiyama T, et al. Uroneurological assessment of spina bifida cystica and occulta. Neurourol Urodyn. 2003;22(4):328-34. [Medline].
Snodgrass WT, Adams R. Initial urologic management of myelomeningocele. Urol Clin North Am. Aug 2004;31(3):427-34, viii. [Medline].
Stone, AR. Neurourologic evaluation and urologic management of spinal dysraphism. Neurosurg Clin N Am. 1995;6(2):269-277. [Medline].
Sutherland RS, Mevorach RA, Baskin LS, Kogan BA. Spinal dysraphism in children: an overview and an approach to prevent complications. Urology. Sep 1995;46(3):294-304. [Medline].
Tarcan T, Bauer S, Olmedo E, et al. Long-term followup of newborns with myelodysplasia and normal urodynamic findings: Is followup necessary?. J Urol. Feb 2001;165(2):564-7. [Medline].
Further Reading
Keywords
neurospinal dysraphism, meningocele, myelomeningocele, lipomeningocele, spina bifida, neural tube defects, neurogenic bladder, spinal dysraphism, spina bifida occulta, dysraphism, renal function, incontinent urinary diversion, myelodysplasia, neurogenic bladder dysfunction, Arnold-Chiari malformation, sacral agenesis, voiding dysfunction, diabetes mellitus, vesicoureteral reflux, renal scarring, urinary tract infections, UTI, renal failure, pyelonephritis, detrusor hyperreflexia, dyssynergia, hypospadias, cryptorchidism, hydroceles, hernia
Differential Diagnoses & Workup: Myelodysplasia and Neurogenic Bladder Dysfunction